Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies

por Elías, E.E., Almejún, M.B., Colado, A., Cordini, G., Vergara-Rubio, M., Podaza, E., Risnik, D., Cabrejo, M., Fernández-Grecco, H., Bezares, R.F., Custidiano, M.R., Sánchez-Ávalos, J.C., Vicente, Á., Garate, C.M., Borge, M., Giordano, M., Gamberale, R.